Promising effect of in-situ lyticase enzyme therapy on peritoneal dialysis catheter obstruction from Acremonium fungal biofilm: A case report
| Autor: | Pisut Katavetin, Thana Thongsricome, Nopparat Maeboonruen, Somchai Eiam-Ong, Preeyarat Pavatung, Talerngsak Kanjanabuch |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Coronavirus disease 2019 (COVID-19) medicine.medical_treatment 030106 microbiology 030231 tropical medicine Catheter Obstruction Salvage therapy Case Report Microbiology Peritoneal dialysis 03 medical and health sciences Fungal peritonitis 0302 clinical medicine medicine lcsh:QH301-705.5 Lyticase lcsh:R5-920 biology business.industry Acremonium Peritoneal catheter obstruction biology.organism_classification Fungal biofilm Surgery Catheter Infectious Diseases lcsh:Biology (General) lcsh:Medicine (General) business |
| Zdroj: | Medical Mycology Case Reports Medical Mycology Case Reports, Vol 30, Iss, Pp 26-28 (2020) |
| ISSN: | 2211-7539 |
| Popis: | We reported the first clinical use of lyticase enzyme in salvaging the peritoneal dialysis (PD) catheter obstruction from Acremonium fungal biofilm during the COVID-19 pandemic era with an impressive result in PD patient presenting with fungal peritonitis and ultrafiltration failure. The organism species was disclosed from PD effluent and catheter cultures. Adjuvant treatment with in-situ lyticase may be considered for catheter salvage therapy if the catheter could not promptly removed in time. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|